Sun Pharmaceutical Industries Independent Director Gautam Doshi Mr. Gautam resigns
Sun Pharmaceutical Industries (SUNPHARMA) said Gautam Doshi Mr. Gautam, Independent Director, has resigned; and Gautam Doshi and placed has resigned. The company is valued at about ₹4.22 lakh crore.
What happened
In a filing with the BSE on 12 October 2026 at 08:04 PM, Sun Pharmaceutical Industries (SUNPHARMA) said that Gautam Doshi Mr. Gautam, Independent Director, has resigned; and Gautam Doshi and placed has resigned.
From the filing: "Gautam Doshi (DIN: 00004612) has tendered his resignation as a Non-Executive, Independent Director of the Company with effect from 12 October 2026, citing personal reasons."
Company snapshot
Sun Pharmaceutical Industries is a large-cap company in the Healthcare sector, with a market value of about ₹4.22 lakh crore.
The stock last traded at ₹1,760, against a 52-week range of ₹1,583.7–₹2,046.9 (14.0% below the high).
Before this filing the shares had moved −5.4% over the month and −9.4% over three months. Average daily turnover over the last 20 sessions was about ₹271 crore.
Promoters held 54.48% at the end of Q1 FY27; 1.65% of promoter shares were pledged. Foreign institutions owned 14.53% and domestic institutions 22.18%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 13,851 | 2,278.6 | 9.5 |
| Q2 FY26 | 14,478 | 3,118 | 13 |
| Q3 FY26 | 15,521 | 3,368.8 | 14 |
| Q4 FY26 | 14,612 | 2,714 | 11.3 |
| Q1 FY27 | 15,300 | 2,894.8 | 12.1 |
What history shows
BCEIE has no earlier management change filing from this company on record since May 2026.
Across 108 similar disclosures by other Healthcare companies, shares moved +0.8% on average the next day and +1.7% over five days; 48% of them rose the next day.
Market-wide, 3,928 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 12 October 2026: Board meeting — Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
- Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) Stock Price, News, Quote & History
- Sun Pharmaceutical Industries (NSEI:SUNPHARMA) Stock Forecast & Analyst Predictions
- Sun Pharmaceutical board to consider ₹15,000 crore NCD issue on October 12
- India's Sun Pharmaceuticals to consider raising $1.55 billion via debentures
- SUNPHARMA Outlook for the Week (October 12, 2026 – October 16, 2026)
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.